Is Anthem Biosciences Ltd debt-free?

Yes, Anthem Biosciences Ltd is debt-free with a debt-to-equity ratio of 0.05.

Home

Anthem Biosciences Ltd

Anthem Biosciences Ltd Financials

Anthem Biosciences Ltd Financial Statement

Anthem Biosciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Anthem Biosciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	1,417.54	1,056.92	1,231.26
Operating Expenses Annual	912.65	627.87	665.80
Operating Profit Annual	575.41	568.23	614.43
Interest Annual	9.14	6.75	10.09
Depreciation	81.49	63.70	57.76
Net Profit Annual	374.78	385.67	405.99
Tax Annual	109.99	112.11	140.60

Particulars	Mar 2024
Total Revenue Annual	1,417.54
Operating Expenses Annual	912.65
Operating Profit Annual	575.41
Interest Annual	9.14
Depreciation	81.49
Net Profit Annual	374.78
Tax Annual	109.99

Anthem Biosciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	342.79	348.87	40.62
Cash Flow from Operations	164.41	318.98	333.35
Cash Flow from Investing	-191.76	-377.91	-205.78
Cash Flow from Financing	-131.59	52.85	180.68
Cash Flow at the End	183.85	342.79	348.87

Particulars	Mar 2024
Cash Flow at the Beginning	342.79
Cash Flow from Operations	164.41
Cash Flow from Investing	-191.76
Cash Flow from Financing	-131.59
Cash Flow at the End	183.85

Anthem Biosciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	40.60	48.86	49.90
PBIT Margin (%)	34.85	42.83	45.21
PBT Margin (%)	31.09	37.91	40.73
Net PROFIT Margin (%)	26.44	36.49	32.97
Return On Networth / Equity (%)	20.40	22.27	39.48
Return On Networth /Employed (%)	24.74	27.47	49.38
Return On Assets (%)	18.77	23.35	35.94
Total Debt / Equity (X)	0.08	0.05	0.07
Asset Turnover Ratio (%)	0.71	0.64	1.09

Particulars	Mar 2024
PBDIT Margin (%)	40.60
PBIT Margin (%)	34.85
PBT Margin (%)	31.09
Net PROFIT Margin (%)	26.44
Return On Networth / Equity (%)	20.40
Return On Networth /Employed (%)	24.74
Return On Assets (%)	18.77
Total Debt / Equity (X)	0.08
Asset Turnover Ratio (%)	0.71

Anthem Biosciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	477.71	448.89	329.01
Total Current Assets Annual	1,445.49	1,319.62	1,097.08
Non Current Assets Annual	878.74	673.39	522.10
Total Shareholders Funds Annual	1,933.07	1,741.62	1,355.46
Total Assets Annual	2,324.23	1,993.02	1,619.18

Particulars	Mar 2024
Fixed Assets Annual	477.71
Total Current Assets Annual	1,445.49
Non Current Assets Annual	878.74
Total Shareholders Funds Annual	1,933.07
Total Assets Annual	2,324.23

Anthem Biosciences Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Anthem Biosciences Ltd Financials

As of Jul 21, 2025, Anthem Biosciences Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Anthem Biosciences Ltd is with a debt-to-equity ratio of 0.05.

In FY 2024 , Anthem Biosciences Ltd recorded a total revenue of approximately 1,840.65 Cr marking a significant milestone in the company's financial performance.

Anthem Biosciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.3% annually, respectively..

Anthem Biosciences Ltd's current PE ratio is .

Anthem Biosciences Ltd's ROCE averaged 25.5% from the FY ending March 2024 to 2025, with a median of 25.5%. It peaked at 27.7% in March 2025, reflecting strong capital efficiency over the period..

Anthem Biosciences Ltd's latest EBIT is Rs. 720.51 Cr, surpassing the average EBIT of Rs. 607.21 Cr over the 5 years..